Mutual of America Capital Management LLC Increases Holdings in Sotera Health (NASDAQ:SHC)

Mutual of America Capital Management LLC increased its stake in Sotera Health (NASDAQ:SHC) by 15.9% during the third quarter, Holdings Channel.com reports. The institutional investor owned 82,654 shares of the company’s stock after buying an additional 11,342 shares during the period. Mutual of America Capital Management LLC’s holdings in Sotera Health were worth $1,380,000 as of its most recent filing with the SEC.

Other institutional investors also recently added to or reduced their stakes in the company. Victory Capital Management Inc. lifted its stake in Sotera Health by 25.7% in the third quarter. Victory Capital Management Inc. now owns 32,610 shares of the company’s stock valued at $545,000 after purchasing an additional 6,666 shares during the last quarter. Versor Investments LP purchased a new position in Sotera Health in the 3rd quarter valued at approximately $337,000. State of New Jersey Common Pension Fund D bought a new stake in Sotera Health during the 3rd quarter valued at $2,121,000. Capital Performance Advisors LLP purchased a new stake in shares of Sotera Health during the third quarter worth $91,000. Finally, Amalgamated Bank boosted its holdings in shares of Sotera Health by 10.9% in the third quarter. Amalgamated Bank now owns 70,347 shares of the company’s stock worth $1,175,000 after acquiring an additional 6,911 shares during the period. Institutional investors own 91.03% of the company’s stock.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the transaction, the director now owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. The trade was a 16.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 55.12% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on SHC. Barclays upped their price target on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research report on Tuesday, August 6th. Citigroup upped their target price on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, November 6th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research report on Thursday, November 21st. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Sotera Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.50.

Sotera Health Stock Performance

NASDAQ:SHC opened at $13.30 on Tuesday. The company has a market capitalization of $3.77 billion, a price-to-earnings ratio of 53.20 and a beta of 2.08. The business has a 50 day moving average of $15.54 and a 200 day moving average of $13.99. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.44.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company had revenue of $285.47 million for the quarter, compared to the consensus estimate of $278.64 million. During the same period last year, the business posted $0.18 earnings per share. The firm’s quarterly revenue was up 8.5% compared to the same quarter last year. On average, sell-side analysts predict that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.